626 results on '"Steffen, Björn"'
Search Results
52. Der geheime Schlüsselaustausch und das Diffie-Hellman-Protokoll
53. Entwurf und Kryptoanalyse von monoalphabetischen Kryptosystemen
54. Die Enigma und moderne Kryptosysteme
55. Polyalphabetische Kryptosysteme und deren Kryptoanalyse
56. Die Suche nach Sicherheit und modulares Rechnen
57. Von Geheimschriften zu Kryptosystemen
58. Anwendungen der Public-Key-Kryptographie und Kommunikationsprotokolle
59. Zahlentheoretische Public-Key-Kryptosysteme und RSA
60. Clinical Impact of Colonization with Multidrug-Resistant Organisms on Outcome after Autologous Stem Cell Transplantation: A Retrospective Single-Center Study
61. Kapitel 27 - Akute Leukämien
62. Bloodstream infections with gram-negative organisms and the impact of multidrug resistance in patients with hematological malignancies
63. Supplementary Materials from S100 Family Members and Trypsinogens Are Predictors of Distant Metastasis and Survival in Early-Stage Non-Small Cell Lung Cancer
64. Das Konzept der Public-Key-Kryptographie
65. Komplexitätstheoretische Konzepte und eine neue Definition der Sicherheit
66. Der geheime Schlüsselaustausch und das Diffie-Hellman-Protokoll
67. Perfekte Sicherheit und das One-Time-Pad-Kryptosytem
68. Die Enigma und moderne Kryptosysteme
69. Polyalphabetische Kryptosysteme und deren Kryptoanalyse
70. Entwurf und Kryptoanalyse von monoalphabetischen Kryptosystemen
71. Zahlentheoretische Public-Key-Kryptosysteme und RSA
72. Die Suche nach Sicherheit und modulares Rechnen
73. Anwendungen der Public-Key-Kryptographie und Kommunikationsprotokolle
74. Von Geheimschriften zu Kryptosystemen
75. On the Power of Advice and Randomization for the Disjoint Path Allocation Problem
76. Venetoclax-Based Salvage Therapy Improves Outcome in Relapsed/Refractory AML Patients Eligible for Intensive Treatment: A Propensity Score Matching Analysis
77. Mutated IKZF1is an independent marker of adverse risk in acute myeloid leukemia
78. Impact of trisomy 19 on outcome according to genetic makeup in patients with acute myeloid leukemia
79. Midostaurin in addition to intensive chemotherapy in acute myeloid leukemia with t(8;21) and KIT and/or FLT3-ITD mutations: results of the SAL MIDOKIT trial
80. Early‐onset venous thromboembolisms in newly diagnosed non‐promyelocytic acute myeloid leukemia patients undergoing intensive induction chemotherapy
81. On the Advice Complexity of the Online L(2,1)-Coloring Problem on Paths and Cycles
82. A Short Introduction to Classical Cryptology as a Way to Motivate High School Students for Informatics
83. Why Teaching Informatics in Schools Is as Important as Teaching Mathematics and Natural Sciences
84. A randomized phase 2 trial of nintedanib and low-dose cytarabine in elderly patients with acute myeloid leukemia ineligible for intensive chemotherapy
85. Results of the Risk-Adapted, MRD-Stratified GMALL Trial 08/2013 in 281 T-ALL / T-Lbl Patients: Excellent Outcome of Standard Risk Thymic T-ALL
86. Single Versus Double Induction with "7+3" Containing 60 Versus 90 Mg Daunorubicin for Newly Diagnosed AML: Results from the Randomized Controlled SAL Dauno-Double Trial
87. Outcome of 841 Older Patients (>55 yrs) with Newly Diagnosed Ph/BCR-ABL Negative ALL Prospectively Treated According to Pediatric-Based, Age-Adapted GMALL Protocols
88. In Patients with Relapsed/Refractory AML Sequential Conditioning and Immediate Allogeneic Stem Cell Transplantation (allo-HCT) Results in Similar Overall and Leukemia-Free Survival Compared to Intensive Remission Induction Chemotherapy Followed By Allo-HCT: Results from the Randomized Phase III ASAP Trial
89. Proteomic Characterization of Acute Myeloid Leukemia
90. Tandem Duplications of the UBTF gene in Adult AML: A Rare but Recurrent Alteration Associated with Myelodysplasia and Poor Outcome
91. Portraying Immunity to Sars-Cov-2 after mRNA-Vaccination in Patients with Multiple Myeloma
92. Blinatumomab Alternating With Low-Intensity Chemotherapy (CT) Treatment for Older Adults With Newly Diagnosed Philadelphia (Ph)-Negative B-Cell Precursor Acute Lymphoblastic Leukemia (BCP-ALL) is Well Tolerated and Efficacious: Safety Run-In Results for the Phase 3 Randomized Controlled Golden Gate Study
93. Venetoclax Plus High-Dose Cytarabine and Mitoxantrone As Feasible and Effective Novel Treatment for Relapsed AML: Results of the Phase-I SAL Relax Trial
94. On the advice complexity of the online [formula omitted]-coloring problem on paths and cycles
95. The Steiner Tree Reoptimization Problem with Sharpened Triangle Inequality : (Extended Abstract)
96. Teaching Public-Key Cryptography in School
97. Clinical impact of colonization with multidrug‐resistant organisms on outcome after allogeneic stem cell transplantation in patients with acute myeloid leukemia
98. Creating and Testing Textbooks for Secondary Schools : An Example: Programming in LOGO
99. New Molecular Therapy Targets in Acute Myeloid Leukemia
100. Quizartinib and High-dose Ara-C plus Mitoxantrone in Relapsed/Refractory AML with FLT3-ITD
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.